These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35733299)

  • 1. Giant cell myocarditis after first dose of BNT162b2 - a case report.
    Hirsch VG; Schallhorn S; Zwadlo C; Diekmann J; Länger F; Jonigk DD; Kempf T; Schultheiss HP; Bauersachs J
    Eur J Heart Fail; 2022 Jul; 24(7):1319-1322. PubMed ID: 35733299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.
    Freise NF; Kivel M; Grebe O; Meyer C; Wafaisade B; Peiper M; Zeus T; Schmidt J; Neuwahl J; Jazmati D; Luedde T; Bölke E; Feldt T; Jensen BEO; Bode J; Keitel V; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; van Griensven M; Rezazadeh A; Flaig Y; Kirchner J; Antoch G; Schelzig H; Matuschek C
    Eur J Med Res; 2022 Jun; 27(1):80. PubMed ID: 35655235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
    Dionne A; Sperotto F; Chamberlain S; Baker AL; Powell AJ; Prakash A; Castellanos DA; Saleeb SF; de Ferranti SD; Newburger JW; Friedman KG
    JAMA Cardiol; 2021 Dec; 6(12):1446-1450. PubMed ID: 34374740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
    Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
    JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocarditis following mRNA COVID-19 vaccination: call for endomyocardial biopsy.
    Kiblboeck D; Klingel K; Genger M; Traxler S; Braunsteiner N; Steinwender C; Kellermair J
    ESC Heart Fail; 2022 Jun; 9(3):1996-2002. PubMed ID: 35194974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    Oster ME; Shay DK; Su JR; Gee J; Creech CB; Broder KR; Edwards K; Soslow JH; Dendy JM; Schlaudecker E; Lang SM; Barnett ED; Ruberg FL; Smith MJ; Campbell MJ; Lopes RD; Sperling LS; Baumblatt JA; Thompson DL; Marquez PL; Strid P; Woo J; Pugsley R; Reagan-Steiner S; DeStefano F; Shimabukuro TT
    JAMA; 2022 Jan; 327(4):331-340. PubMed ID: 35076665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
    BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
    Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
    JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
    PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine.
    Woo W; Kim AY; Yon DK; Lee SW; Hwang J; Jacob L; Koyanagi A; Kim MS; Moon DH; Jung JW; Choi JY; Jung SY; Eun LY; Lee S; Shin JI; Smith L
    J Med Virol; 2022 Apr; 94(4):1566-1580. PubMed ID: 34862617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
    Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
    JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
    Kim HW; Jenista ER; Wendell DC; Azevedo CF; Campbell MJ; Darty SN; Parker MA; Kim RJ
    JAMA Cardiol; 2021 Oct; 6(10):1196-1201. PubMed ID: 34185046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
    Witberg G; Barda N; Hoss S; Richter I; Wiessman M; Aviv Y; Grinberg T; Auster O; Dagan N; Balicer RD; Kornowski R
    N Engl J Med; 2021 Dec; 385(23):2132-2139. PubMed ID: 34614329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
    Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
    Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocarditis after vaccination against covid-19.
    Gellad WF
    BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
    [No Abstract]   [Full Text] [Related]  

  • 16. Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech).
    Lin W; Yip ACL; Evangelista LKM; Wong RCC; Tan HC; Lim TW; Singh D
    Pacing Clin Electrophysiol; 2022 Sep; 45(9):1097-1100. PubMed ID: 35306680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 mRNA vaccine (Comirnaty)-induced myocarditis.
    Wong J; Sharma S; Yao JV; Aggarwal A; Grigg L
    Med J Aust; 2022 Feb; 216(3):122-123. PubMed ID: 35075640
    [No Abstract]   [Full Text] [Related]  

  • 18. Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.
    Park J; Brekke DR; Bratincsak A
    Cardiol Young; 2022 Jan; 32(1):146-149. PubMed ID: 34180390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocarditis following COVID-19 mRNA vaccination.
    Abu Mouch S; Roguin A; Hellou E; Ishai A; Shoshan U; Mahamid L; Zoabi M; Aisman M; Goldschmid N; Berar Yanay N
    Vaccine; 2021 Jun; 39(29):3790-3793. PubMed ID: 34092429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prominent J Waves and Ventricular Fibrillation Caused by Myocarditis and Pericarditis After BNT162b2 mRNA COVID-19 Vaccination.
    Uesako H; Fujikawa H; Hashimoto S; Wakabayashi T
    Can J Cardiol; 2022 Jun; 38(6):844-847. PubMed ID: 35151782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.